The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In Vitro Diagnostics Quality Control Market Research Report 2024
Synopsis
In vitro diagnostics quality controls have taken on a crucial role in modern healthcare due to the better accuracy of diagnosis offered by their use.
The global In Vitro Diagnostics Quality Control market was valued at US$ 617 million in 2023 and is anticipated to reach US$ 732.9 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics Quality Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics Quality Control.
Report Scope
The In Vitro Diagnostics Quality Control market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Diagnostics Quality Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostics Quality Control companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bio-Rad
Helena Laboratories
Ortho Clinical Diagnostics
Randox Laboratories
Roche
Seracare
Siemens Healthineers
Sun Diagnostics
Thermo Fisher Scientific
Sysmex
Quantimetrix
Segment by Type
Product
Service
Segment by Application
Hospitals
Clinical Laboratories
Research and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics Quality Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In vitro diagnostics quality controls have taken on a crucial role in modern healthcare due to the better accuracy of diagnosis offered by their use.
The global In Vitro Diagnostics Quality Control market was valued at US$ 617 million in 2023 and is anticipated to reach US$ 732.9 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for In Vitro Diagnostics Quality Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Diagnostics Quality Control.
Report Scope
The In Vitro Diagnostics Quality Control market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vitro Diagnostics Quality Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Diagnostics Quality Control companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bio-Rad
Helena Laboratories
Ortho Clinical Diagnostics
Randox Laboratories
Roche
Seracare
Siemens Healthineers
Sun Diagnostics
Thermo Fisher Scientific
Sysmex
Quantimetrix
Segment by Type
Product
Service
Segment by Application
Hospitals
Clinical Laboratories
Research and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Diagnostics Quality Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostics Quality Control Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Product
1.2.3 Service
1.3 Market by Application
1.3.1 Global In Vitro Diagnostics Quality Control Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Research and Academic Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostics Quality Control Market Perspective (2019-2030)
2.2 In Vitro Diagnostics Quality Control Growth Trends by Region
2.2.1 Global In Vitro Diagnostics Quality Control Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vitro Diagnostics Quality Control Historic Market Size by Region (2019-2024)
2.2.3 In Vitro Diagnostics Quality Control Forecasted Market Size by Region (2025-2030)
2.3 In Vitro Diagnostics Quality Control Market Dynamics
2.3.1 In Vitro Diagnostics Quality Control Industry Trends
2.3.2 In Vitro Diagnostics Quality Control Market Drivers
2.3.3 In Vitro Diagnostics Quality Control Market Challenges
2.3.4 In Vitro Diagnostics Quality Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostics Quality Control Players by Revenue
3.1.1 Global Top In Vitro Diagnostics Quality Control Players by Revenue (2019-2024)
3.1.2 Global In Vitro Diagnostics Quality Control Revenue Market Share by Players (2019-2024)
3.2 Global In Vitro Diagnostics Quality Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostics Quality Control Revenue
3.4 Global In Vitro Diagnostics Quality Control Market Concentration Ratio
3.4.1 Global In Vitro Diagnostics Quality Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostics Quality Control Revenue in 2023
3.5 In Vitro Diagnostics Quality Control Key Players Head office and Area Served
3.6 Key Players In Vitro Diagnostics Quality Control Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostics Quality Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostics Quality Control Breakdown Data by Type
4.1 Global In Vitro Diagnostics Quality Control Historic Market Size by Type (2019-2024)
4.2 Global In Vitro Diagnostics Quality Control Forecasted Market Size by Type (2025-2030)
5 In Vitro Diagnostics Quality Control Breakdown Data by Application
5.1 Global In Vitro Diagnostics Quality Control Historic Market Size by Application (2019-2024)
5.2 Global In Vitro Diagnostics Quality Control Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vitro Diagnostics Quality Control Market Size (2019-2030)
6.2 North America In Vitro Diagnostics Quality Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vitro Diagnostics Quality Control Market Size by Country (2019-2024)
6.4 North America In Vitro Diagnostics Quality Control Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostics Quality Control Market Size (2019-2030)
7.2 Europe In Vitro Diagnostics Quality Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vitro Diagnostics Quality Control Market Size by Country (2019-2024)
7.4 Europe In Vitro Diagnostics Quality Control Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostics Quality Control Market Size (2019-2030)
8.2 Asia-Pacific In Vitro Diagnostics Quality Control Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vitro Diagnostics Quality Control Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vitro Diagnostics Quality Control Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Diagnostics Quality Control Market Size (2019-2030)
9.2 Latin America In Vitro Diagnostics Quality Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vitro Diagnostics Quality Control Market Size by Country (2019-2024)
9.4 Latin America In Vitro Diagnostics Quality Control Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostics Quality Control Market Size (2019-2030)
10.2 Middle East & Africa In Vitro Diagnostics Quality Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vitro Diagnostics Quality Control Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vitro Diagnostics Quality Control Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories In Vitro Diagnostics Quality Control Introduction
11.1.4 Abbott Laboratories Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Bio-Rad
11.2.1 Bio-Rad Company Detail
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad In Vitro Diagnostics Quality Control Introduction
11.2.4 Bio-Rad Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.2.5 Bio-Rad Recent Development
11.3 Helena Laboratories
11.3.1 Helena Laboratories Company Detail
11.3.2 Helena Laboratories Business Overview
11.3.3 Helena Laboratories In Vitro Diagnostics Quality Control Introduction
11.3.4 Helena Laboratories Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.3.5 Helena Laboratories Recent Development
11.4 Ortho Clinical Diagnostics
11.4.1 Ortho Clinical Diagnostics Company Detail
11.4.2 Ortho Clinical Diagnostics Business Overview
11.4.3 Ortho Clinical Diagnostics In Vitro Diagnostics Quality Control Introduction
11.4.4 Ortho Clinical Diagnostics Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.4.5 Ortho Clinical Diagnostics Recent Development
11.5 Randox Laboratories
11.5.1 Randox Laboratories Company Detail
11.5.2 Randox Laboratories Business Overview
11.5.3 Randox Laboratories In Vitro Diagnostics Quality Control Introduction
11.5.4 Randox Laboratories Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.5.5 Randox Laboratories Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche In Vitro Diagnostics Quality Control Introduction
11.6.4 Roche Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Seracare
11.7.1 Seracare Company Detail
11.7.2 Seracare Business Overview
11.7.3 Seracare In Vitro Diagnostics Quality Control Introduction
11.7.4 Seracare Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.7.5 Seracare Recent Development
11.8 Siemens Healthineers
11.8.1 Siemens Healthineers Company Detail
11.8.2 Siemens Healthineers Business Overview
11.8.3 Siemens Healthineers In Vitro Diagnostics Quality Control Introduction
11.8.4 Siemens Healthineers Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.8.5 Siemens Healthineers Recent Development
11.9 Sun Diagnostics
11.9.1 Sun Diagnostics Company Detail
11.9.2 Sun Diagnostics Business Overview
11.9.3 Sun Diagnostics In Vitro Diagnostics Quality Control Introduction
11.9.4 Sun Diagnostics Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.9.5 Sun Diagnostics Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific In Vitro Diagnostics Quality Control Introduction
11.10.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Sysmex
11.11.1 Sysmex Company Detail
11.11.2 Sysmex Business Overview
11.11.3 Sysmex In Vitro Diagnostics Quality Control Introduction
11.11.4 Sysmex Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.11.5 Sysmex Recent Development
11.12 Quantimetrix
11.12.1 Quantimetrix Company Detail
11.12.2 Quantimetrix Business Overview
11.12.3 Quantimetrix In Vitro Diagnostics Quality Control Introduction
11.12.4 Quantimetrix Revenue in In Vitro Diagnostics Quality Control Business (2019-2024)
11.12.5 Quantimetrix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
